Delivery Order SPE2DB22D9112-SPE2DB24FE6XD

Award Date 9/3/24
Potential Completion Date 9/24/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,137.60 contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,557.52, is for the supply of Xolair 150 mg/ml syringes. This award is under a larger DLA medical supply chain indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the agency to issue delivery orders for a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,189.60 firm fixed-price delivery order is for the supply of Xolair 150 mg/ml syringes. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,547.40 firm fixed-price delivery order is for the supply of Xolair 150 mg/mL syringes and is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,605.50, is for the supply of Xolair 150 mg/mL syringes to support the medical needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,926.60, is for the delivery of Xolair 150 mg/ml syringes. It is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 150 mg/mL XOLAIR syringes and does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $1,547.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a period of performance through September 25, 2024, and is for the provision of the pharmaceutical product Xolair 150 mg/mL syringe. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,284.40 firm fixed-price contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is for the delivery of Xolair 150 mg/ml syringes to the Defense Logistics Agency (DLA). The $6,189.60 firm fixed-price delivery order is part of a larger DLA indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a wide range of pharmaceutical products, including common medications and...
  • SPE2DB22D9112
    Indefinite Delivery Contract
  • SPE2DB22D9112-SPE2DB24FE6XD
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, provides for the delivery of Xolair 150 mg/ml syringes to the Defense Logistics Agency (DLA). The contract, valued at $6,189.60, is a firm fixed-price delivery order with no set-aside designation.

DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group supplies both routine and critical medications to support the diverse medical requirements of the Department of Defense (DoD) healthcare system.

Generated 12/3/24, 10:02 AM